Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,014 public trials 2,030 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Telerehabilitation and Lymphoma Patients

NCT04822389

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: University Hospital Brno Brno, Czechia

View Trial Details

Completed

Subclinical Cardio-toxicities Evaluation With Strain Rate Echocardiography After Chemotherapy and/or Mediastinal Radiotherapy in Patient With Lymphoma

NCT03480087

Conditions: Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +18 more
Locations: SC Ematologia - AOU Città della salute e della Scienza di Torino Torino, Italy

View Trial Details

Completed

Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

NCT01005277

Conditions: Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, Adult Acute Promyelocytic Leukemia With PML-RARA, +21 more
Locations: Childrens Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

NCT03023046

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

APG-115 in Patients With Advanced Solid Tumors or Lymphomas

NCT02935907

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: START Midwest Grand Rapids, Michigan, United States

The START Center for Cancer Care San Antonio, Texas, United States

View Trial Details

Completed

Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL)

NCT05366257

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Novartis Investigative Site East Hanover, New Jersey, United States

View Trial Details

Completed

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

NCT02921828

Conditions: Acute Kidney Injury, Arrhythmias, Cardiac, Blood Protein Disorders, +54 more
Locations: Local Institution - Japan No City Provided, New Jersey, United States

Shinko Hospital Kobe, Hyōgo, Japan

View Trial Details

Completed

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

NCT00900055

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +29 more
Locations: Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States

View Trial Details

Completed

CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI)

NCT05349201

Conditions: Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-Cell Lymphoma (DLBCL), Hematologic Diseases, +14 more
Locations: Novartis Investigative Site East Hanover, New Jersey, United States

View Trial Details

Completed

Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies

NCT02795182

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations: St Vincent's Hospital Darlinghurst, New South Wales, Australia

Concord Hospital Sydney, New South Wales, Australia

Royal Hobart Hospital Hobart, Tasmania, Australia

Monash Hospital Clayton, Victoria, Australia

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions